Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification
CONCLUSIONS: In conclusion, our study identifies LATPM4A as a promising biomarker for prognosis and immune characteristics in glioma.PMID:38613802 | DOI:10.18632/aging.205736
Source: Aging - Category: Biomedical Science Authors: Yongqi Ding Yike Jiang Hong Zeng Minqin Zhou Xuanrui Zhou Zichuan Yu Jingying Pan Xitong Geng Yanting Zhu Hao Zheng Shuhan Huang Yiyang Gong Huabin Huang Chengfeng Xiong Da Huang Source Type: research
More News: Biology | Biomedical Science | Brain Tumor | Cancer | Cancer & Oncology | Epithelial Cancer | Genetics | Glioma | Immunotherapy | Pancreas | Pancreatic Cancer | Study